Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen Bz.ast;44 allotypes

Haematologica

Volumn 97, Issue 1, 2012, Pages 98-106

  Badrinath, Soumya ^a   Saunders, Philippa ^b   Huyton, Trevor ^a   Aufderbeck, Susanne ^a   Hiller, Oliver ^a   Blasczyk, Rainer ^a   Bade Doeding, Christina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

HLA polymorphism; Peptide binding motif; Peptide loading complex; Tapasin

Indexed keywords

HLA B44 ANTIGEN; TAPASIN;

ALLOTYPE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; COMPUTER ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STABILITY; SEQUENCE HOMOLOGY;

ALLELES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; COMPUTATIONAL BIOLOGY; EPITOPES; GENE EXPRESSION; GENE SILENCING; HEK293 CELLS; HLA-B44 ANTIGEN; HUMANS; MEMBRANE TRANSPORT PROTEINS; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING;

EID: 84855213587     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.046037     Document Type: Article

References (27)

1. Petersdorf EW. Risk assessment in haematopoietic stem cell transplantation: histocompatibility. Best Pract Res Clin Haematol. 2007;20(2):155-70.
2. Petersdorf EW. Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol. 2008;20(5):588-93.
3. Wearsch PA, Cresswell P. The quality control of MHC class I peptide loading. Curr Opin Cell Biol. 2008;20(6):624-31.
4. Ackerman AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol. 2004;5 (7):678-84.
5. Wearsch PA, Cresswell P. Selective loading of high-affinity peptides onto major histo-compatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol. 2007;8(8):873-81.
6. Zernich D, Purcell AW, Macdonald WA, Kjer-Nielsen L, Ely LK, Laham N, et al. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med. 2004;200(1):13-24.
7. Williams A P, Peh CA, Purcell AW, McCluskey J, Elliott T. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity. 2002;16(4):509-20.
8. Park B, Kim Y, Shin J, Lee S, Cho K, Fruh K, et al. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity. 2004;20(1):71-85.
9. Chelvanayagam G. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics. 1996;45(1):15-26.
10. Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med. 2003;198 (5):679-91.
11. Archbold JK, Macdonald WA, Gras S, Ely LK, Miles JJ, Bell MJ, et al. Natural microp-olymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J Exp Med. 2009;206(1): 209-19.
12. Fleischhauer K, Avila D, Vilbois F, Traversari C, Bordignon C, Wallny HJ. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens. 1994; 44(5):311-7.
13. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY. Bone marrow-allograft rejection by T lym-phocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med. 1990;323(26):1818-22.
14. Hogan KT, Clayberger C, Bernhard EJ, Walk SF, Ridge J P, Parham P, et al. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3. J Immunol. 1988;141 (7):2519-25.
15. Mattson DH, Shimojo N, Cowan EP, Baskin JJ, Turner RV, Shvetsky BD, et al. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral pep-tide-specific cytotoxic T lymphocytes. J Immunol. 1989;143(4): 1101-7.
16. Shimojo N, Cowan EP, Engelhard VH, Maloy WL, Coligan JE, Biddison WE. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73. J Immunol. 1989;143(2):558-64.
17. Tynan FE, Elhassen D, Purcell AW, Burrows JM, Borg NA, Miles JJ, et al. The immuno-genicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med. 2005;202(9):1249-60.
18. Burrows JM, Wynn KK, Tynan FE, Archbold J, Miles JJ, Bell MJ, et al. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV. Eur J Immunol. 2007;37(4):946-53.
19. Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H, et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood. 2007;110(7):2235-41.
20. Barnstable CJ, Bodmer W F, Brown G, Galfre G, Milstein C, Williams AF, et al. Production of monoclonal antibodies to group A ery-throcytes, HLA and other human cell surface antigens new tools for genetic analysis. Cell. 1978;14(1):9-20.
21. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev. 1979;47:3-61.
22. Hirosawa M, Hoshida M, Ishikawa M, Toya T. MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci. 1993;9(2):161-7.
23. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714-23.
24. Sieker F, Straatsma T P, Springer S, Zacharias M. Differential tapasin dependence of MHC class I molecules correlates with conforma-tional changes upon peptide dissociation: a molecular dynamics simulation study. Mol Immunol. 2008;45(14): 3714-22.
25. Hillen N, Mester G, Lemmel C, Weinzierl AO, Muller M, Wernet D, et al. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype. Eur J Immunol. 2008;38(11):2993-3003.
26. Lemmel C, Weik S, Eberle U, Dengjel J, Kratt T, Becker HD, et al. Differential quantitative analysis of MHC ligands by mass spectrom-etry using stable isotope labeling. Nat Biotechnol. 2004;22(4):450-4.
27. Lo Conte L, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol. 1999;285(5):2177-98.